Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Hanh Giai Ngo"'
Autor:
Yingnan Si, Kai Chen, Hanh Giai Ngo, Jia Shiung Guan, Angela Totoro, Zhuoxin Zhou, Seulhee Kim, Taehyun Kim, Lufang Zhou, Xiaoguang Liu
Publikováno v:
Pharmaceutics, Vol 14, Iss 1, p 146 (2022)
Triple-negative breast cancers (TNBCs) are heterogeneous and metastatic, and targeted therapy is highly needed for TNBC treatment. Recent studies showed that extracellular vesicles (EV) have great potential to deliver therapies to treat cancers. This
Externí odkaz:
https://doaj.org/article/44b01bbe71484da4bce774dcba57fe82
Autor:
Yingnan Si, Ya Zhang, Jia-Shiung Guan, Hanh Giai Ngo, Angela Totoro, Ajeet Pal Singh, Kai Chen, Yuanxin Xu, Eddy S. Yang, Lufang Zhou, Runhua Liu, Xiaoguang (Margaret) Liu
Publikováno v:
Vaccines, Vol 9, Iss 8, p 882 (2021)
Triple-negative breast cancers (TNBCs) are frequently recurrent due to the development of drug resistance post chemotherapy. Both the existing literature and our study found that surface receptor CD47 (cluster of differentiation 47) was upregulated i
Externí odkaz:
https://doaj.org/article/350f5db6b6644dd2bf70d684a275c610
Autor:
Lufang Zhou, Ajeet Pal Singh, Jia-Shiung Guan, Yuanxin Xu, Kai Chen, Hanh Giai Ngo, Eddy S. Yang, Qing Wang, Yingnan Si, Ya Zhang, Xiaoguang Margaret Liu
Publikováno v:
Cancers
Cancers, Vol 13, Iss 3749, p 3749 (2021)
Volume 13
Issue 15
Cancers, Vol 13, Iss 3749, p 3749 (2021)
Volume 13
Issue 15
Triple-negative breast cancers (TNBCs) are highly aggressive and recurrent. Standard cytotoxic chemotherapies are currently the main treatment options, but their clinical efficacies are limited and patients usually suffer from severe side effects. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4384d4ce15c066911e689b04341aaac2
http://europepmc.org/articles/PMC8345094
http://europepmc.org/articles/PMC8345094